These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29470253)

  • 21. Growing from common ground: nontuberculous mycobacteria and bronchiectasis.
    Van Braeckel E; Bosteels C
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
    Khan O; Chaudary N
    Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.
    Banaschewski B; Verma D; Pennings LJ; Zimmerman M; Ye Q; Gadawa J; Dartois V; Ordway D; van Ingen J; Ufer S; Stapleton K; Hofmann T
    J Cyst Fibros; 2019 Sep; 18(5):714-720. PubMed ID: 31138497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines.
    Ku JH; Henkle E; Aksamit TR; Barker A; Brunton AE; Winthrop KL;
    Clin Infect Dis; 2023 Jan; 76(2):338-341. PubMed ID: 36134755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nontuberculous mycobacteria infections in immunosuppressed hosts.
    Henkle E; Winthrop KL
    Clin Chest Med; 2015 Mar; 36(1):91-9. PubMed ID: 25676522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
    Lee SFK; Laughon BE; McHugh TD; Lipman M
    Curr Opin Pulm Med; 2019 May; 25(3):271-280. PubMed ID: 30865034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
    Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
    BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery.
    van der Laan R; Snabilié A; Obradovic M
    Respir Res; 2022 Dec; 23(1):376. PubMed ID: 36566170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
    Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
    Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
    Sawka A; Burke A
    Clin Chest Med; 2023 Dec; 44(4):815-828. PubMed ID: 37890918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
    Ying C; Zhang L; Jin X; Zhu D; Wu W
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nontuberculous Mycobacteria.
    Tan S; Kasperbauer S
    Semin Respir Crit Care Med; 2021 Aug; 42(4):567-586. PubMed ID: 34261181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.
    van Ingen J
    Clin Chest Med; 2015 Mar; 36(1):43-54. PubMed ID: 25676518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review.
    Anidi IU; Olivier KN
    Clin Chest Med; 2023 Dec; 44(4):839-845. PubMed ID: 37890920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.